Primary care paradigm for management of sarcoidosis, part 1

Journal of the National Medical Association

Volumn 89, Issue 3, 1997, Pages 181-190

  Young Jr , Roscoe C ^a,b   Rachal, Raylinda E ^a   Nelson Knuckles, Bettie ^a   Arthur, Clarissa N ^a   Nevels, Harold V ^a  

^a Metropolitan Nashville General Hospital   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Patient management; Primary care; Sarcoidosis

Indexed keywords

CORTICOSTEROID;

HUMAN; MULTIMODALITY CANCER THERAPY; PATIENT CARE; PRIMARY HEALTH CARE; PROGNOSIS; REVIEW; SARCOIDOSIS;

ADRENAL CORTEX HORMONES; COMBINED MODALITY THERAPY; CONTINUITY OF PATIENT CARE; HUMANS; PATIENT CARE TEAM; PRIMARY HEALTH CARE; PROGNOSIS; SARCOIDOSIS; SARCOIDOSIS, PULMONARY;

EID: 0031090043     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Hutchinson J. Anomalous disease of the skin of the finger: papillary psoriasis. In: Illustration of Clinical Surgery. London, England: J and A Churchill; 1978:42-43.
2. Scadding JG. Sarcoidosis. London, England: Erye and Spottiswoode; 1966.
3. Shahady EJ. Teaching the principles of family medicine. New Zealand Family Physician. 1982;10:24-26.
4. Donnelly S, Ward K, Fitzgerald MX. Analysis of patients lost to follow-up at a sarcoid clinic. Sarcoidosis. 1991;8:45-50.
5. Lieberman J. Elevation of serum angiotensin-converting enzyme (ACE) level in sarcoidosis. Am J Med. 1975;59:365-372.
6. Weinberger SE, Kelman JA, Elson NA, Young RC Jr, Reynolds HY, Fulmer JD, et al. Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med. 1978;89:459-466.
7. Israel HL. Report of the Medical Group. International Conference on Sarcoidosis. Am Rev Respir Dis. 1961;84:171-173.
8. Young RC Jr, Rachal RE. Sarcoidosis. In: Edlich RF, Spyker DA, eds. Current Emergency Therapy. Rockville, Md: Aspen; 1985:970-97.5.
9. Young RC Jr, Rachal RE, Cowan CL. When should sarcoidosis be treated? J Natl Med Assoc. 1986;78:811-821.
10. 67Gallium scans. Clin Res. 1979; 27:400A. Abstract.
11. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med. 1983;308:793-800.
12. Pinkston P, Bitterman PB, Crystal RG. Corticosteroid modulation of lung T-cell interleukin-2 release and lung T-cell proliferation in pulmonary sarcoidosis. In: Tenth International Conference on Sarcoidosis and Other Granulomatous Disorders. Baltimore, Md: Johns Hopkins University; 1984:48. Abstract.
13. Martinet Y, Pinkston P, Crystal RG. Cyclosporin: a suppression of the spontaneous release of monocyte chemotactic factor by lung T-cell. In: Tenth International Conference on Sarcoidosis and Other Granulomatous Disorders. Baltimore, Md: Johns Hopkins University; 1984:46. Abstract.
14. James DG, Thomson AD. The course of sarcoidosis and its modification by treatment. Lancet. 1959;1:1057-1061.
15. Stone DJ, Schwartz A. A long-term study of sarcoid and its modification by steroid therapy. Am J Med. 1966;41:528-551.
16. Sharma OP, Colp C, Williams MH Jr. Course of pulmonary sarcoidosis with and without corticosteroid therapy as determined by pulmonary function studies. Am J Med. 1966;41:541-551.
17. Siltzbach LE. Sarcoidosis: clinical features and management. Med Clin North Am. 1967;51:483-502.
18. Johns CJ, Ball WC Jr. Steroids in pulmonary parenchymal sarcoidosis with serial measurements of pulmonary function. In: Turiaf et Chabot. Rapports de la IV Conference. La Sarcoidose. Paris, France: Masson et Cie; 1967;742-748.
19. James DG, Carstairs LS, Trowell J, Sharma OP. Treatment of sarcoidosis. Report of a controlled therapeutic trial. Lancet. 1967;526-528.
20. Israel HL. The treatment of sarcoidosis. Postgrad Med J. 1970;46:537-540.
21. Israel HL, Fouts DW, Beggs RA. A controlled trial of prednisone treatment of sarcoidosis. Am Rev Respir Dis. 1973;107:609-614.
22. Young RL, Lordon RE, Krumholtz RA, Harkleroad LE, Branham GE, Weg JG. Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy. Ann Intern Med. 1970;73:207-212.
23. Colp C. Sarcoidosis: course and treatment. Med Clin North Am. 1977;61:1267-1278.
24. DeRemee RA. The treatment of sarcoidosis. In: Lieberman J. Sarcoidosis. Orlando, Fla: Grune and Stratton; 1985:195-204.
25. Sheagren JN, Simon HB, Rich RR. Therapy of sarcoidosis initiated with alternate day prednisone. J Natl Med Assoc. 1973;65:391-398.
26. Fauci AS. Alternate-day corticosteroid therapy. Am J Med. 1978;64:729-731. Editorial.
27. Figaroa-Lebron R. Twice a week steroids in sarcoidosis. In: Tenth International Conference on Sarcoidosis and Other Granulomatous Disorders. Baltimore, Md: Johns Hopkins University Press; 1984:123. Abstract.
28. Selroos OB. Budesonide for treatment of pulmonary sarcoidosis. Tenth International Conference on Sarcoidosis and Other Granulomatous Disorders. In Johns CJ. Ann NY Acad Sci. 1986;465:713-721.
29. Sharma O, Hughes DTD, James DG, Naish JP. Immunosuppressive therapy with azathraprine in sarcoidosis. In: Levinsky L, Macholda F, eds. Fifth International Conference on Sarcoidosis. Prague, Czechoslavakia: Charles University Press; 1971:635-637.
30. Israel HL. Effects of chlorambucil and methotrexate in sarcoidosis. In: Levinsky L, Macholda F, eds. Fifth International Conference on Sarcoidosis. Prague, Czechoslovakia: Charles University Press; 1971:632-634.
31. Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, et al. Methotrexate for the treatment of Crohn's disease. N Engl J Med. 1995;332:292-297.
32. Weinblatt ME. Methotrexate for chronic diseases in adults. N Engl J Med. 1995;332:330-331.
33. Morse SI, Cohn ZA, Hirsh JG. The treatment of sarcoidosis with chloroquine. Am J Med. 1961;30:779-784.
34. James DG. Drugs for the treatment of sarcoidosis. In: Iwai K, Hosada Y. Proceedings of the VIth International Conference on Sarcoidosis. Tokyo: University Park Press; 1974.
35. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: reliability and validity in a patient population. Med Care. 1988;26:724-735.
36. Sharma OP. Splenic rupture in sarcoidosis: report of an unusual case. Am Rev Respir Dis. 1967;96:101-102.
37. Israel HL, Ostrow A. Sarcoidosis and aspergilloma. In: Levinsky L, Macholda F, eds. Fifth International Conference on Sarcoidosis. Prague: Charles University Press; 1971:495-497.
38. Metcalf JR, Vijic I, Sahn SA. Massive hemoptysis in patients with advanced pulmonary sarcoidosis treated with bronchial artery embolization. In: Tenth International Conference on Sarcoidosis and Other Granulomatous Disorders. Baltimore, Md: Johns Hopkins University; 1984:p129. Abstract.
39. Johnson BA, Duncan SR, Ohori NP, Paradis IL, Yousem SA, Girgurich WF, et al. Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis. 1993;148:1373-1377.
40. Lam CR. The surgical aspects of sarcoidosis: with particular reference to some apparent cures following surgical procedures. Arch Surg. 1968;97:459-468.
41. Hackney RL Jr, Young RC Jr, McDaniel W. Sarcoidosis. In: Conn RB. Current Diagnosis 7. Philadelphia, Pa: WB Saunders Co; 1985:1296-1302.
42. Gibson KF, Aguayo SM, Flowers JC, Ford JG, Jackson JH, Lwebuga-Mukasa JS, et al. Special report: respiratory diseases disproportionately affecting minorities. The NHLBI Working Group. Chest. 1995;108:1380-1392.
43. Lynch JP III, Strieter RM. External clues to extrapulmonary sarcoidosis. Journal of Respiratory Disease. 1990;11:619-626.
44. Gilg I. Klinische undersogelser over Boeck's sarcoid: Behandling og forlob. Ugeskr Laeger. 1956;118:46-47.
45. Lofgren S, Stavenow S. Course and prognosis of sarcoidosis. Am Rev Respir Dis. 1961;84:71-75.
46. Hosada Y, Hiraga Y, Furuta M, Niitu Y, Iwai K, Odaka M, et al. In: Iwai K, Hosada Y, eds. Epidemiology of Sarcoidosis in Japan. Proceedings of the VIth International Conference on Sarcoidosis. Tokyo, Japan: University of Tokyo Press; 1974:297-302.
47. Cowdell RH. Sarcoidosis: with special reference to diagnosis and prognosis. Quarterly Journal of Medicine. 1954;23:29-55.
48. Bunim JJ, Kimberg DV, Thomas LB, VanScott JJ, Klatskin G. The syndrome of sarcoidosis, psoriasis and gout. Ann Intern Med. 1962;57:1018-1040.
49. Hirschman RJ, Johns CJ. Hemoglobin studies in sarcoidosis. Ann Intern Med. 1962;57:1018-1040.
50. Trujillo NP, Halstead LS, Ticktin HE. Chronic ulcerative colitis, xanthomatous biliary cirrhosis and sarcoidosis. Medical Annals of the District of Columbia. 1967;36:170-174.
51. Haroutunian LM, Fisher AM, Smith EW. Tuberculosis and sarcoidosis. Bulletin of the Johns Hopkins Hospital 1964;115:1-28.
52. Young RC Jr, Titus-Dillon PY, Schneider ML, Shelton TG, Hackney RL Jr, Harden KA. Sarcoidosis in Washington, DC: clinical observations in 105 patients. Arch Intern Med. 1970;125:101-105.
53. Chusid EL. Clubbing of the fingers in sarcoidosis: a critical assessment. In: Jones-Williams W, Davies BH, eds. Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. Alpha Omega Pub; 1980:543-546.